R. Mazumder

Advancements in Formulation Approaches for Retinoblastoma: An Overview

Retinoblastoma (Rb) is an aggressive intraocular tumour that usually affects children and is primarily driven by mutations in the RB1 gene. The treatment of Rb is extremely difficult because of high rates of tumour growth and various anatomical factors that impede effective drug delivery systems. A comprehen...

A Glance at the Recent Nanoparticle-based Therapeutic Approaches Towards Glioblastoma Multiforme.

INTRODUCTION Glioblastoma multiforme, abbreviated as GBM, is a malignant form of brain cancer with no definitive cure or method of prevention and an unknown cellular origin that prevents a comprehensive understanding of its complex pathophysiology. Although still in its early stages, nanotechnology-based therapeutic st...

Enhanced Brain Biodistribution of Quercetin and Rutin Co-Loaded Pegylated PLGA Nanoparticles Via Intranasal Delivery for Neuroblastoma Therapy

Advancement in Inflammation-responsive Drug Delivery System for Chronic Inflammation.

Inflammation-Responsive Drug Delivery System (IR-DDS) is proposed as a novel strategy for targeted therapy of the chronic inflammation-associated diseases: inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and sepsis. These smart systems take advantage of the characteristic pathological microenvironment in i...